Objective: Post-dural puncture headache (PDPH) is a common complication of diagnostic lumbar punctures. Both a non-cutting needle design and the use of smaller size needles have been shown to greatly reduce the risk of PDPH. Nevertheless, larger cutting needles are still widely used. This study describes the process of changing the needle in an outpatient clinic of a Danish neurology department. Methods: Prospective interventional trial. Phase 1: 22 G cutting needle. Phase 2: 25 G non-cutting needle. Practical usability of each needle was recorded during the procedure, while the rate of PDPH and the occurrence of socioeconomic complications were acquired from a standardized questionnaire. Results: 651 patients scheduled for diagnostic lumbar punctures were screened for participation and 501 patients were included. The response rate was 80% in both phases.
Introduction
Diagnostic lumbar punctures are frequently implemented in the routine evaluation of patients with neurological symptoms. Indications for the procedure are extensive ranging from suspicion of an inflammatory or infectious disease to evaluation of chronic neurodegenerative disorders. Post-dural puncture headache (PDPH) is a common complication of the test, with younger patients being particularly at risk [1] . Although proven to reduce the occurrence of PDPH, the usage of small, non-cutting needles is still not widespread in neurology departments [2] . In a UK survey, a cutting needle was used in over 70% of neurology units, and only two of 48 units reported using a gauge smaller than 22 G [3] . In a US survey, the use of non-cutting needles was even lower, as only 2% of the responding neurologists reported that they routinely used this type of needle [4] . The reasons given for the continued use of larger cutting needles vary from economical and practical concerns to a lack of up-to-date knowledge [2, 4] .
According to The International Classification of Headaches (ICHD-II), set out by the International Headache Society, PDPH is a postural headache that arises within 5 days of a dural puncture. The headache is aggravated within 15 min of assuming an erect posture, and improves within 15 min of lying down. Furthermore, at least one of five additional symptoms must be present. These include neck stiffness, tinnitus, hypacusia, photophobia, and nausea [5] . There may also be severe complications following dural puncture and PDPH. In a literature review, Zeidan et al. [6] discovered 46 cases of unilateral or bilateral intracranial subdural hematomas following spinal and epidural anesthesia, of which at least six were mortal. Furthermore, spinal hematomas [7] , postpartum seizures [2] , coma [8] , and cranial nerve palsies [9] have been attributed to dural puncture and PDPH. The incidence of PDPH varies between <1% and 70%, and is dependent on both patient and procedural characteristics [10] . Factors associated with increased risk of PDPH include young age [11] [12] [13] , low body-mass-index (BMI) [12, 14] , chronic headache or prior PDPH [11, 12] , female gender [12] , large needle diameter [15, 16] , and a cutting needle design [10, [14] [15] [16] [17] [18] , PDPH is most likely caused by persistent leakage from a dural defect, which subsequently leads to intracranial hypotension [1] . As a consequence, reduced support of intracranial structures, particularly during an erect position, leads to a downward pull on pain-sensitive structures. This is substantiated by downward displacement of the posterior fossa content, observed in orthostatic headache patients [19, 20] , and by the rare occurrence of both cranial nerve palsies and subdural hematomas following dural puncture and PDPH [6, 9] . Furthermore, intracranial cerebrospinal fluid (CSF) depletion possibly leads to compensatory vasodilation, as predicted by the Monro-Kellie doctrine. Not unlike migraine, this could cause a substantial headache.
Owing to the apparent paradox between the evidence supporting the use of smaller, non-cutting needles, and the widespread use of larger, cutting needles, we performed a prospective, interventional trial to provide greater insight into the feasibility and potential benefits of using a 25 G non-cutting needle, as opposed to the "classical" Quincke cutting 22 G needle, for diagnostic lumbar punctures. We recorded the practical usability of the specific needle, the rate of PDPH, and the occurrence of socioeconomic complications.
Methods
The study was approved by the Regional Ethics Committee. We obtained informed consent from all patients. The study took place at the outpatient clinic of the Department of Neurology, Vejle Hospital, Denmark (Fig. 1) , and the study population consisted of consecutive patients older than 15 years undergoing scheduled or sub-acute diagnostic lumbar puncture.
Patients evaluated for a novel onset and persisting headache syndrome and/or refusing participation were not included (n = 150). We designed the study as a two phase interventional trial, in which we used the traumatic Spinocan 22 G needle in phase 1 and the non-cutting Pencan 25 G needle in phase 2. Phase 1 ran from 1 March 2012 to 4 October 2012, with a sharp cross-over to phase 2, which ended on 25 June 2013. Patients were blinded to both phase and needle type.
The first year residents of the department performed the lumbar punctures, with the opportunity to call on an associate for assistance if necessary. If the department failed to perform the procedure, assistance from the anesthesiology department was acquired. In both phases, the procedure was performed using local anesthesia and the stylet was reinserted before the needle was withdrawn. When using the traumatic needle the bevel was arranged parallel to the spine. An introducer cannula was used in phase 2. Data collected included patient demographics, BMI, headache history, total number of puncture attempts, removed spinal fluid volume, and need for assistance. Following the procedure, the patients were provided with a questionnaire that included information on headache duration and severity, orthostatic components, additional symptoms, influence on activities of daily living and work, and, finally, if any treatment modalities had been used. The questionnaire scored headache as either non-existent, mild or severe. A nurse provided instructions and a stamped and addressed envelope for returns. We defined PDPH as any orthostatic headache accompanied by at least one additional symptom, according to the ICHD-II classification. If the patient experienced severe headache, we likewise classified the PDPH as severe.
We predefined the primary outcome as the relative risk of PDPH and severe PDPH depending on needle type, and calculated this in a multivariate regression model reporting risk-ratios. We categorized exposure variables according to clinical experience and previously published studies, and included these in the model, if univariate analysis showed an effect. We compared baseline demographics and procedural characteristics between phases using a Student's t test for continuous variables, and Fisher's exact test for ratios. We evaluated the practical usability of each needle in a multivariate model reporting risk-ratios of the need for associate and anesthetic assistance. We assessed the number of extra attempts required per patient in a Poisson regression, adjusted for needle type, age, gender, and BMI. We compared number of days spent either away from work or bedridden during each phase using the Wilcoxon rank-sum test, and compared the need for various treatment modalities using Fisher's exact test. We performed data analysis using STATA version 11.0 statistical software.
Results
A total of 651 patients underwent lumbar puncture during the study period. Of these, 501 met the inclusion criteria and were included in the study. A total of 96 patients were lost to followup (19%); however, these were evenly distributed between phase 1 (N = 50) and phase 2 (N = 46). A total of 199 and 206 patients completed the study in phases 1 and 2, respectively (Fig. 1 ). There were no significant differences between groups of patients in the two phases regarding age, gender, BMI, history of headache, prior PDPH, and CSF volume drawn (Table 1) . Furthermore, adherence to local anesthetics and stylet reinsertion was even between phases. In phase 1, a parallel cutting axis was used in 97% of lumbar punctures.
A total of 21 patients developed PDPH after lumbar puncture with the non-cutting 25 G needle, vs 50 with the traumatic 22 G needle (10% vs 25%) ( Table 2 ). In a multivariate regression analysis adjusting for age, gender, and BMI, this corresponded to a 50% risk reduction when using the smaller, non-cutting needle (RR 0.50, 95% CI 0.32-0.76, p = 0.001). When only including severe PDPH in the model, the risk-ratio decreased and remained statistically significant (RR 0.43, 95% CI 0.26-0.73, p = 0.002). The models further showed that age under 50 years, female gender, and BMI under 20 all significantly increased the risk of both PDPH and severe PDPH (Table 3) . In univariate analyses, the risk of PDPH was not influenced by a history of chronic headache (RR 1.01, p = 0.856), previous PDPH (RR 1.04, p = 0.477), or the need for multiple attempts during the procedure (RR 1.06, p = 0.801).
After the procedure, a total of 175 days away from work was reported for patients during phase 1, vs only 55 during phase 2 (p < 0.001). Similarly, the total number of days spent bedridden was substantially higher during phase 1 than during phase 2 (217 vs 102, p < 0.001). The number of patients who needed hospitalization (17 vs 2, p < 0.001) and bloodpatch (10 vs 2, p = 0.019) was also significantly higher during phase 1 ( Table 2 ). The median admission time was found to be 1 day according to hospital records.
In multivariate regression models, the need for associate assistance when using the non-cutting 25 G needle was reduced by 42% (RR 0.58, p = 0.005), while no significant difference in the need for anesthesiologist assistance was observed. Furthermore, the need for multiple attempts during the procedure was reduced from 44% to 30% (Table 2 ). This effect was significant when registering the number of additional attempts in a Poisson regression adjusted for age, gender, and BMI (Table 3) . While age and gender did not influence procedural success, a higher BMI tended to increase the need for associate assistance (RR 1.03, p = 0.078), and significantly increased the need for multiple attempts (IRR 1.04, p < 0.001). To test for launching challenges during phase two, we compared the first 50 patients with the subsequent 156 patients. Though a slight early increase in the need for associate assistance was observed, no significant differences between procedural success was observed (need for associate assistance, early 22% vs late 15%, p = 0.27; more than one attempt needed, early 34% vs late 29%, p = 0.60).
When using the unadjusted data, the numbers needed to treat to avoid specific outcomes were: PDPH 7, severe PDPH 8, hospitalization 13, and bloodpatch application 25.
Discussion
Despite the overwhelming evidence in support of the use of smaller, non-cutting needles for diagnostic lumbar punctures, the use of larger cutting needles is still widespread in neurological departments [3, 4, 21] . In our outpatient clinic, where a cutting 22 G needle had previously been the needle of choice, we performed a prospective, interventional study, in order to test the feasibility, drawbacks, and potential benefits of changing the needle to a 25 G non-cutting needle. While adjusting for potential confounders, we were able to confirm the findings of previous studies, namely, that using a smaller, non-cutting needle significantly reduces the risk of PDPH [10, [14] [15] [16] [17] [18] . Furthermore, after changing the needle, a significant reduction in both socioeconomic complications and procedural difficulties was observed (Tables 2 and 3) . 
Table 4
Cost comparison between phases. Source: Expense rates reproduced from Dakka et al. [13] .
Interestingly, the need for multiple attempts did not increase the risk of PDPH in our study. This is consistent with the pathogenesis of the disease, such that only a successful attempt, penetrating the dura, is capable of inducing PDPH. In addition, accounting for the fact that in vitro investigation has confirmed that both smaller needle size and a non-cutting design reduce CSF leakage, these observations seriously question the classic notion; that the risk of PDPH is somehow dependent on the skill or the experience of the operator [18, 22, 23] .
Our findings, that both young age and female gender are significant risk factors for PDPH, are in general agreement with those of previous studies [11] [12] [13] . However, some discrepancy with regard to the relationship between female gender and the risk of PDPH exists in the literature [11] . Although 61 of 71 PDPH cases in our study were female, women were also highly overrepresented in patients younger than 50 years (157 vs 59). This underscores the need to assess the risk of PDPH in a multivariate design.
Socioeconomic complications
To our knowledge, only two previous studies have estimated the potential cost savings depending on choice of needle for diagnostic lumbar punctures [13, 24] . Both studies were of retrospective design, with several limitations. However, similar results were achieved with regard to total healthcare costs per lumbar puncture using the cutting needle (Dakka et al., $239; Tung et al., $192). Both studies also showed a costreducing effect of using non-cutting needles. Using the suggested costs of lumbar puncture kits, hospital admission, and bloodpatch application of Dakka et al., we showed similar costs per lumbar puncture with the 22 G cutting needle in our study; $187. Since intravenous caffeine is not routinely administered for treatment of PDPH at our department this expense was omitted from the calculations. Of particular importance, we observed a substantial cost reduction of $142, or 76%, per lumbar puncture after the switch to the 25 G non-cutting needle ( Table 4) .
As also stated by both Dakka and Tung, these calculations do not account for the loss of resources to the patients (loss of income) or society (lost productivity) amongst other variables [13, 24] . Our findings that the total number of days spent away from work was reduced from 175 to 55 after switching the needle suggest that this contribution is substantial (Table 2 ).
Ease of use
Few studies have systematically reported the success rate of diagnostic lumbar punctures dependent on needle type. Thomas et al. [18] reported a slightly higher rate of multiple attempts or failure to perform the procedure when using the atraumatic needle. However, this was not a significant finding, but was consistent with the subjective assessment that the operators found the noncutting needle more difficult to use. Of particular interest, the use of an introducer cannula was left to the operator's discretion in this study, whereas in our study it was obligatory. We speculate that the use of a rigid introducer cannula with the non-cutting needle helps guide the needle during the procedure, which could explain the positive results of our study. Although we report a similar failure rate of the primary operator to Thomas et al. when using the non-cutting needle (both ∼16%, Table 2 ), this was achieved with a much thinner needle (25 G vs 20 G) . Similar to our results, Halpern and Preston found a higher frequency of procedural difficulties with cutting needles in a meta-analysis [16] . Importantly, when introducing the 25 G non-cutting needle, no significant launching difficulties were observed, and the overall success-rate was 96% in our department (Table 2) . Although use of smaller needles naturally extends the duration of the CSF sampling, this has limited clinical implications, given the small samples typically needed for diagnostic purposes (3-12 mL). According to our regular personnel, this did not interfere with the patient flow of the outpatient clinic. Furthermore, needle design has not been shown to significantly influence spinal fluid flow rates, either in clinical or experimental settings [18, 25] .
Limitations and conclusion
This study has some limitations; primarily, the non-randomized design should be noted. The significance of this limitation is reduced by the prospective interventional design, the very similar demographics of each phase, and the multivariate approach to the data-analysis. We did not register indications for performing lumbar punctures; this limitation is, however, reduced by the large sample size and the comparable demographics of each phase. Although patients were blinded to both phase and needle type, this was of course not possible for operators. Prior to the study initiation, the traumatic needle was the needle of choice. Additionally, during the study period new residents were continuously introduced as part of the typical rotation of younger doctors at the department. This limits potential experience bias achieved during phase two. Since outcome measures were self-reported by questionnaire, we chose a rather simple score for assessing the degree of headache in order to achieve as high a response rate and degree of accuracy as possible.
In conclusion, our results strongly support the use of a noncutting, 25 G needle for diagnostic lumbar punctures and the study shows that this needle can be easily implemented in the outpatient unit of a Neurological department. When combined with an introducer cannula and local anesthetics, the procedure was easier to perform and improved all predefined outcomes, including rate of PDPH and overall costs. This is fully in line with the recommendations of the American Academy of Neurology [21, 26] . We have listed the advantages of the two types of needles in Table 5 .
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